5q14.3 Microdeletion Syndrome

Description

The newly described 5q14.3 microdeletion syndrome includes severe intellectual deficit with no speech, stereotypic movements and epilepsy.

Clinical Features

Top most frequent phenotypes and symptoms related to 5q14.3 Microdeletion Syndrome

  • Intellectual disability
  • Seizures
  • Global developmental delay
  • Short stature
  • Generalized hypotonia
  • Hearing impairment
  • Microcephaly
  • Growth delay
  • Hypertelorism
  • Strabismus

And another 65 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

5q14.3 Microdeletion Syndrome Is also known as monosomy 5q14.3, del(5)(q14.3), mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

5q14.3 Microdeletion Syndrome Recommended genes panels

Panel Name, Specifity and genes Tested/covered
MEF2C Sequence Analysis.

By Baylor Miraca Genetics Laboratories (United States).

MEF2C
Specificity
100 %
Genes
100 %
MEF2C Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories (United States).

MEF2C
Specificity
100 %
Genes
100 %
MEF2C Sequence Analysis (Prenatal Diagnosis).

By Baylor Miraca Genetics Laboratories (United States).

MEF2C
Specificity
100 %
Genes
100 %
Epilepsy Advanced Sequencing and CNV Evaluation.

By Athena Diagnostics Inc (United States).

SCN1A, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SHH, ST3GAL3, ST3GAL5, STIL, SIX3, SLC2A1, SLC35A2, SLC6A1, SLC6A8, SLC9A6, SMC1A, KDM5C, SMS , (...)

View the complete list with 214 more genes
Specificity
1 %
Genes
100 %
MEF2C Sequencing and CNV Evaluation.

By Athena Diagnostics Inc (United States).

MEF2C
Specificity
100 %
Genes
100 %
Epilepsy Advanced Sequencing and CNV Evaluation - Infantile Spasms.

By Athena Diagnostics Inc (United States).

SCN2A, ST3GAL3, SLC35A2, SPTAN1, CDKL5, STXBP1, CACNA2D1, ARX, SLC25A22, ADSL, TBL1XR1, FOXG1, GABRB3, GRIN2A, MEF2C, NR2F1
Specificity
7 %
Genes
100 %
Syndromic Autism Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

SCN1A, SCN2A, BRAF, SLC2A1, SLC9A6, SMC1A, KDM5C, CDKL5, STXBP1, TBR1, TCF4, MED12, TSC1, TSC2, UBE3A, HDAC8, CNTNAP2, FOXP2, CACNA1C, NSD1 , (...)

View the complete list with 63 more genes
Specificity
2 %
Genes
100 %
Rett-Angelman Syndrome 2nd-Tier Sequencing Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

SLC2A1, SLC9A6, CDKL5, TCF4, UBE3A, CNTNAP2, PCDH19, ZEB2, ARX, MBD5, EHMT1, CTNNB1, FOLR1, FOXG1, MECP2, MEF2C, NRXN1, OPHN1, ATRX, PNKP , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
100 %

You can get up to 97 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM ORPHANET Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1 LACTOSE INTOLERANCE, ADULT TYPE NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3 COSTELLO SYNDROME; CSTLO NICOLAIDES-BARAITSER SYNDROME; NCBRS MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W